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Novel naphthalene-based 5·(BArF)8 capsule allows for the size-selective inclusion of C60 from 
fullerene mixtures. Its size selectivity towards C60 has been rationalized by its dynamic adaptability 
in solution that has been investigated by Molecular Dynamics. Additionally, 5·(BArF)8 encapsulates 
C60-derivatives such as C60-PCBM and N-methyl-pyrrolidine-C60. The latter can be separated from 
C60 since  5·(BArF)8 displays distinct affinity between them. 
The metal-ligand coordination approach has led to the preparation of sophisticated discrete three-
dimensional (3D) structures, which are of great interest due to their intrinsic complexity, which 
conveys multifunctionality, and potential applications in fields such as molecular catalysis, sensing 
or purification.1–3 Indeed, the possibility of tuning the dimensions of the confined space by 
modifying the 3D molecular structure is an attractive feature to gain control over the guest affinity, 
and allows for the preparation of extended libraries of coordination capsules.4,5 On the other hand, 
purification of fullerenes is remarkable due to their applications in materials science and 
medicine.6,7 Even though fullerenes extracts are easily available, the selective purification of a 
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 specific fullerene cage is still a challenging task basically accomplished by means of high 
performance liquid chromatography (HPLC) techniques, that are generally tedious, time- and 
energy consuming.8 Another challenging issue is the separation of parent fullerenes from their 
corresponding derivatives, which is also mainly restricted to HPLC separation. C60-derivatives such 
as [6,6]-phenyl C61 butyric acid methyl ester (PCBM-C60) or fulleropyrrolidines, present promising 
applications in material science; but they need to be available in a pure form to display full 
efficiency.9,10  To date, numerous examples of 3D molecular receptors based in metal-ligand 
coordination bonds and capable of hosting fullerenes have been reported.11–14 However, the 
separation of a single fullerene by size-confinement effects is not straightforward since the 
molecular receptors display high affinity for different-sized fullerenes simultaneously.15 In most 
reported examples a higher affinity towards Cn (n ≥70) over C60 is observed, due to more significant 
solvophovic effects and the more extended π-surface of larger fullerenes that enhances capsule-
fullerene interaction.16–19 The reverse trend is observed in very limited examples.20  
Our group previously reported a coordination nanocapsule (4·(BArF)8) capable of encapsulating different 
sized fullerenes from C60 to C84.21 This lack of size selectivity was attributed to its pronounced breathing 
ability and large cavity size. In light of the importance of C60 and its derivatives, herein we report a 
nanocapsule (5·(BArF)8), which bears a smaller cavity, obtained by tuning the length of its spacers. The 
newly designed nanocapsule with naphthalene spacers is capable of exclusively encapsulating smaller C60 
fullerene and its corresponding mono-adduct derivatives in a selective manner.  
New metallo-capsule 5·(X)8 (X = CF3SO3, BArF) was synthesized by coordination driven self-assembly of 
the carboxylate units from ZnII-porphyrin (2) and PdII-based macrocyclic synthons (Pd-1c). 5·(X)8 differs 
from our previously reported capsules 3·(X’)8 (X’= ClO4, CF3SO3) and 4·(X)8 in the nature of the hexaaza 
macrocyclic ligands used to synthesize the ligands (1b-1c) and therefore the corresponding PdII-clip 
building blocks (Scheme 1).21,22 Nanocapsule 3·(X’)8 contained a phenyl ring in its macrocyclic ligands 
(1), and the crystallographic distance between its porphyrins was 7.5 Å. On the other hand, 4·(X)8 included 
a biphenyl moiety in 1b, rendering a PorphZn····PorphZn distance of 14.1 Å measured from X-ray structure 
(Figure 2). While the former capsule 3 was only capable of encapsulating flat anionic π-guests, capsule 4 
could host fullerene molecules up to C84 with very high association constants (up to Ka>108 M-1). For the 
new nanocapsule 5·(X)8, which contains 2,6-disubstituted naphthalene units in the macrocyclic ligand (1c) 
(Figures S1-S27) an intermediate capsule-size was envisioned (Scheme 1).  
  
Scheme 1. Schematic representation of the library of coordination nanocapsules 3-5. (a) Spacers 
used to obtain (b) the tetragonal-prismatic supramolecular capsules 3•(X’)8 (X’= ClO4, CF3SO3), 
4•(X)8 and 5•(X)8 (X= CF3SO3, BArF) (BArF: tetrakis[3,5-bis(trifluoromethyl)phenyl]borate). 
 
Formation of nanocapsule 5·(CF3SO3)8 was first confirmed by High Resolution Mass Spectrometry 
(HRMS) (Figure S28). Then, CF3SO3- anions were exchanged by BArF anions to increase its solubility. 
5·(BArF)8 was obtained in good yield, effectively showing an enhanced solubility in different organic 
solvents, including CH3CN and dichloromethane (DCM). HRMS of 5·(BArF)8 showed ions corresponding 
to the cages with consecutive loss of counteranions (Figure 1a and Figure S29), demonstrating its integrity 
in solution. Full NMR characterization was also performed for 5·(BArF)8 (Figures S30-36). Remarkably, 
the DOSY NMR experiment (CH3CN, 298 K) afforded a diffusion coefficient of D = 3.1·10-10 m2s-1, 
indicating that the dimensions of 58+ correspond to a hydrodynamic radius of 18.5 Å in solution (Figure 
S37 and Figure S38), in line with the value estimated from crystallographic data (see below and Figure 
S38b). 
Crystallographic data was obtained from 5·(CF3SO3)8 crystals at the XALOC beamline of the ALBA 
Synchrotron (Figure 2a and Supplementary Information for Single-Crystal X-Ray Diffraction - SCXRD 
details). Nanocapsule 58+ consists of two parallel tetracarboxylated ZnII-porphyrins linked by four 
macrocyclic dinuclear PdII complexes. The four-carboxylate residues of each porphyrin are linked by means 
 of η1-O monodentate coordination to one PdII center (Figure S38). As in 38+ and 48+,[19,20] 58+ presents a 
tetragonal prismatic geometry bearing a D4 symmetry. The crystallographic PorphZn···PorphZn distance 
in 5·(CF3SO3)8 is 8.2 Å. As expected, this distance lays between the observed in capsules 3·(X’)8 and 4·(X)8 
(see Scheme 1 and Figure 2a). In light of the size contraction with respect to 4·(X)8, it was predicted that 
5·(X)8 will offer a higher affinity to smaller fullerenes. 
Once 5·(BArF)8 was fully characterized, its ability to host fullerenes was tested starting with the 
encapsulation of C60. Here, fast formation of 1:1 host:guest adducts was observed after mixing a 1:1 molar 
solution of 5·(BArF)8 in CH3CN and C60 in toluene. HRMS of the 1:1 C60:5·(BArF)8 mixture showed peaks 
corresponding exclusively to C60⸦5·(BArF)8 (Figure 1b and Figure S39). Data obtained from the UV-Vis 
titration of C60 and 5·(BArF)8 fitted to a 1:1 binding model with an association constant of 1.29 ( 0.42)·105 
M-1 (Figure S40).23 The formation of the host:guest adduct was also evidenced in the 1H-NMR spectrum, 
which showed several signals shifted; specially those corresponding to the aromatic protons of the phenyl 
rings of the porphyrin pointing inwards the cavity (Figure S41). 
Afterwards, the encapsulation of C70 was also attempted and monitored by HRMS. Remarkably, when a 
solution of C70 in toluene was mixed with a solution of 5·(BArF)8 in CH3CN in a 2:1 molar ratio (298 K, 
48 h), peaks corresponding to C70⸦5·(BArF)8 adduct as well as peaks belonging to remaining empty 
capsule were observed (3:2 ratio respectively, see Figure S42). These results indicated a notable lower 
affinity of the capsule towards C70 compared to C60. UV-Vis titration with C70 was in line with HRMS, 
since negligible changes on the Soret band were detected (Fig.S43).  
The encapsulation of C60 might seem surprising based solely on the short Porph-Zn···Porph-Zn distance 
measured in the crystal structure. This distance, 8.2 Å, is much smaller than the van der Waals diameter of 
C60 (10.1 Å), thus indicating that 5·(BArF)8 must undergo important structural changes in solution to be 
able to accommodate C60 (Figure 2a). The latter was explored through Molecular Dynamics (MD) 
simulations using CH3CN as explicit solvent and Cl- as counterions (see Supporting Information for 
details). MD simulations revealed that the Porph-Zn···Porph-Zn distance in empty 5·(Cl)8 swings from 
10.5 to 12.5 Å in solution (Figures 2b-2c and Video VS1 in the SI). On the other hand, MD simulations on 
C60⸦5·(Cl)8 and C70⸦5·(Cl)8 host-guest complexes showed a Porph-Zn···Porph-Zn distance of 12.3 - 13 
Å for C60 system and 12.6 - 13.3 Å for C70 case (Figure S44). Porph-Zn···Porph-Zn distances explored 
during MD trajectory by C70⸦5·(Cl)8 are over the larger Porph-Zn···Porph-Zn distance measured by empty 
5·(Cl)8 during MD, while C60⸦5·(Cl)8 distances are in breathing range (Figure 2b). Indeed, when 
comparing these Porph-Zn···Porph-Zn distances to those observed in the previously reported crystal 
structures of C60⸦4·(BArF)8 and C70⸦4·(BArF)8, 13.1 Å and 13.7 Å for C60 and C70 respectively,21 the idea 
that C70 fullerene is imposing a more severe distortion on the nanocapsule 5 than C60 is reinforced. This 
 large distortion of the nanocapsule 5 required to encapsulate C70 is in agreement with the hampered 
encapsulation of C70 within 5·(BArF)8 and the higher selectivity towards C60. 
Encapsulation experiments with C60 were also performed by using 5·(CF3SO3)8 in the solid state. 
Interestingly, C60 was trapped after adding solid capsule to a solution of the fullerene in toluene (1:8 
capsule:fullerene molar ratio) (Figure S45). Full formation of C60⸦5·(CF3SO3)8 adduct was observed after 
1 h stirring. Note here that the liquid/liquid complexation occurs faster (<5 min, 1:1 capsule:fullerene ratio) 
than the solid/liquid one. The slower rate of the solid/liquid encapsulation is most likely due to the higher 
rigidity of the capsule in the solid state, which restricts its dynamic adaptability needed to accommodate 
C60, as revealed by MD simulations.  
Taking advantage of the higher size-selectivity for C60, nanocapsule 5·(BArF)8 was used to selectively 
separate C60 from fullerene extract (extract composition: 70% C60, 28% C70, 2% higher fullerenes). To this 
end, a solution of 5·(BArF)8 in CH3CN was mixed with a solution of fullerene extract in toluene, in a 1:2 
molar ratio (capsule:fullerenes). Delightfully, HRMS experiments showed that C60 was exclusively 
encapsulated from all the fullerenes mixture (Figure S46). No peaks corresponding to adducts with C70 or 
with other higher fullerenes present in the soot (i.e. C72, C76 or C84) were observed, even using extended 
reaction times. The same experiment was repeated using solid 5·(CF3SO3)8, in which C60 fullerene was also 
solely encapsulated (capsule:fullerene-extract in 1:8 molar ratio, see Figure S47). On the contrary, when 
larger 4·(BArF)8 capsule is added, either in solid or liquid form, to a fullerene extract solution both C60 and 
C70 and other higher fullerenes are encapsulated displaying no size selectivity.21 
 
Figure 1. HRMS of 5·(BArF)8 and its host-guest adducts. HRMS in CH3CN of (a) 5·(BArF)8, (b) 
C60⸦5·(BArF)8, (c) [(mono)-N-pyrrolidine-C60]⸦5·(BArF)8 and (d) [PCBM-C60]⸦5·(BArF)8. 
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Figure 2. Crystal structures of the library of capsules 38+-58+ and illustrations of MD simulation of capsule 
5. a) Lateral view of the crystal structures of 3·(ClO4)8, 4·(BArF)8 and 5·(CF3SO3)8 (counter ions and 
hydrogen atoms are omitted for clarity). b) Zn···Zn distance measured along the 500 ns of Molecular 
Dynamics (MD) trajectory for 5·(Cl)8 (purple), C60⸦5·(Cl)8 (green) and C70⸦5·(Cl)8 (orange) in explicit 
CH3CN solvent. For more clarity, the 10-step averaged value for each point is represented by the purple 
line in the plot. c) Representative snapshots taken along the MD trajectory to illustrate the conformational 
flexibility of 58+. Zn···Zn distances are given in Å, and hydrogen atoms are omitted for clarity. 
 
 
Finally, the ability of 5·(BArF)8 to encapsulate C60 derivatives was also explored. Host-guest studies were 
carried out with PCBM-C60 and N-methylpyrrolidine-C60 (the latter was prepared as previously reported).24 
When a solution of the corresponding derivative in toluene was mixed with a solution of the capsule in 
acetonitrile in a 1:1 molar ration, clean formation of the host-guest complexes was observed by HRMS after 
5 min stirring (Figure 1c-d, Figure S48-49). UV-Vis titration experiments were performed in order to 
estimate the association constant between 5·(BArF)8 receptor and the C60-derivatives. Interestingly, the 
UV-Vis experiment following the formation of [N-methylpyrrolidine-C60]⸦5·(BArF)8  complex gave an 
association constant of 6.60 ( 0.32)·104  M-1 (2-fold smaller than the one obtained for C60, Figure S50) 
and [PCBM-C60]⸦5·(BArF)8 complex gave an association constant of 1.27 ( 2.04)·105 M-1 (Figure S51) 
which is very similar to the one obtained for C60. Encapsulation of both functionalized fullerenes was also 
performed by using 5·(CF3SO3)8 capsule in the solid state. Both species showed complete encapsulation 
after 1 h stirring a capsule suspension in a fullerene-derivative toluene solution (Figures S52 and S53); 
48+58+
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 however, encapsulation of PCBM-C60 was faster as it was evidenced by the HRMS spectrum recorded after 
30 min reaction time compared to the one obtained for N-methylpyrrolidine-C60 (Figures S52 and S53). 
The latter observation is in agreement with the higher association constant obtained for PCBM-C60. 
A competition experiment between C60 fullerene and PCBM-C60 derivative, further supports the similar 
values obtained for their association constants. When 1 equivalent of 5·(BArF)8 capsule was mixed with 
2.5 eq of C60 and 2.5 eq of PCBM-C60, in toluene/acetonitrile (4/1) during 2.5h, very similar peaks on the 
HRMS were observed in line with the similar Ka (see Figure 3a and Figure S54). Interestingly, when a 
solution of 1 equivalent of 5·(BArF)8 capsule was mixed with 2.5 eq of C60 and 2.5 eq of N-
methylpyrrolidine-C60, in toluene/acetonitrile (4/1) during 2.5h, selective encapsulation of C60 occurred. 
The HRMS spectrum of the crude, displayed peaks corresponding to C60⸦5·(BArF)8 adduct and only 
residual peaks corresponding to N-methylpyrrolidine-C60⸦5·(BArF)8 adduct (Figure 3b, Figure S55 and 
S56 for comparable ionization behavior in HRMS). The notable difference between the association 
constants of C60 and C60-fulleropyrrolidine derivative (Ka(C60)/Ka(C60-fulleropyrrolidine) ~ 2), also enabled 
the separation of mono-Prato-C60 from the mixture with C60 using the previously described solid-washing 
strategy.21 When a solid sample of 5·(BArF)8 containing both C60 and N-methylpyrrolidine-C60 was washed 
with CS2, the Prato derivative was released while the C60 fullerene still remained trapped within the 
nanosapule (see Figure S57). 
  
 
Figure 3. HRMS spectra of the competition experiments of a) C60 vs PCBM-C60 and b) C60 vs N-
methylpyrrolidine-C60. 
 
Conclusions 
 
Contraction of the organic macrocyclic ligands of the previously described 4·(BArF)8 capsule, led to the 
new tetragonal prismatic nanocapsule 5·(BArF)8. Remarkably, the size-selectivity imposed by the 
anisotropically contracted nanocapsule allows for the selective separation of C60 from fullerene extract 
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 mixtures. Its capacity to host fullerenes and its size selectivity towards C60 can be rationalized by the 
dynamic adaptability that the capsule structure displays in solution, as shown by MD simulations. 
5·(BArF)8 also encapsulates C60-PCBM and N-methyl-pyrrolidine-C60, displaying a larger affinity for C60 
than for the latter Prato derivative, allowing its selective purification. Nanocapsule 5·(BArF)8 sets the 
knowledge basis for future purification of C60-derivative mixtures.  
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